These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 34360736)
1. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies. Suuring M; Moreau A Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360736 [TBL] [Abstract][Full Text] [Related]
2. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells. Kim SH; Jung HH; Lee CK Yonsei Med J; 2018 Sep; 59(7):807-815. PubMed ID: 30091313 [TBL] [Abstract][Full Text] [Related]
3. Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction - A comparative study. Adnan E; Matsumoto T; Ishizaki J; Onishi S; Suemori K; Yasukawa M; Hasegawa H Clin Immunol; 2016 Dec; 173():96-108. PubMed ID: 27658741 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of clinical grade human tolerogenic dendritic cells. Naranjo-Gómez M; Raïch-Regué D; Oñate C; Grau-López L; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE J Transl Med; 2011 Jun; 9():89. PubMed ID: 21658226 [TBL] [Abstract][Full Text] [Related]
5. Cell-based Tolerogenic Therapy, Experience from Animal Models of Multiple Sclerosis, Type 1 Diabetes and Rheumatoid Arthritis. Stojanovic I; Dimitrijevic M; Vives-Pi M; Mansilla MJ; Pujol-Autonell I; Rodríguez-Fernandez S; Palova-Jelínkova L; Funda DP; Gruden-Movsesijan A; Sofronic-Milosavljevic L; Hilkens CMU; Martinez-Caceres E; Miljkovic D Curr Pharm Des; 2017; 23(18):2623-2643. PubMed ID: 28201972 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells. Wu C; Zhang Y; Jiang Y; Wang Q; Long Y; Wang C; Cao X; Chen G Cell Mol Immunol; 2013 Sep; 10(5):393-402. PubMed ID: 23872920 [TBL] [Abstract][Full Text] [Related]
7. Tolerogenic dendritic cells generated with dexamethasone and vitamin D3 regulate rheumatoid arthritis CD4 Anderson AE; Swan DJ; Wong OY; Buck M; Eltherington O; Harry RA; Patterson AM; Pratt AG; Reynolds G; Doran JP; Kirby JA; Isaacs JD; Hilkens CM Clin Exp Immunol; 2017 Jan; 187(1):113-123. PubMed ID: 27667787 [TBL] [Abstract][Full Text] [Related]
8. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Harry RA; Anderson AE; Isaacs JD; Hilkens CM Ann Rheum Dis; 2010 Nov; 69(11):2042-50. PubMed ID: 20551157 [TBL] [Abstract][Full Text] [Related]
9. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Hilkens CM; Isaacs JD Clin Exp Immunol; 2013 May; 172(2):148-57. PubMed ID: 23574312 [TBL] [Abstract][Full Text] [Related]
10. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance. Castenmiller C; Keumatio-Doungtsop BC; van Ree R; de Jong EC; van Kooyk Y Front Immunol; 2021; 12():643240. PubMed ID: 33679806 [TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128 [TBL] [Abstract][Full Text] [Related]
12. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice. Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L Front Immunol; 2018; 9():290. PubMed ID: 29503651 [TBL] [Abstract][Full Text] [Related]
13. Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases. Morante-Palacios O; Fondelli F; Ballestar E; Martínez-Cáceres EM Trends Immunol; 2021 Jan; 42(1):59-75. PubMed ID: 33293219 [TBL] [Abstract][Full Text] [Related]
14. Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand? Marín E; Cuturi MC; Moreau A Front Immunol; 2018; 9():274. PubMed ID: 29520275 [TBL] [Abstract][Full Text] [Related]
15. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives. Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923 [TBL] [Abstract][Full Text] [Related]
16. Infectious tolerance as candidate therapy for type 1 diabetes: transfer of immunoregulatory properties from human regulatory T cells to other T cells and proinflammatory dendritic cells. Kleijwegt FS; Roep BO Crit Rev Immunol; 2013; 33(5):415-34. PubMed ID: 24099301 [TBL] [Abstract][Full Text] [Related]
17. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity. Passeri L; Marta F; Bassi V; Gregori S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells as targets for therapy in rheumatoid arthritis. Khan S; Greenberg JD; Bhardwaj N Nat Rev Rheumatol; 2009 Oct; 5(10):566-71. PubMed ID: 19798032 [TBL] [Abstract][Full Text] [Related]
19. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Adorini L; Penna G Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030 [TBL] [Abstract][Full Text] [Related]
20. Multidimensional analyses of proinsulin peptide-specific regulatory T cells induced by tolerogenic dendritic cells. Suwandi JS; Laban S; Vass K; Joosten A; van Unen V; Lelieveldt BPF; Höllt T; Zwaginga JJ; Nikolic T; Roep BO J Autoimmun; 2020 Feb; 107():102361. PubMed ID: 31776056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]